All studies
RecruitingOBSERVATIONAL

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

This study is investigating how rare conditions affecting blood vessels impact pregnancy. Conditions like Osler Rendu disease, Marfan syndrome, and certain issues with blood vessel connections (vascular anomalies) can sometimes cause serious problems for both the mother and her baby during pregnancy. Currently, we don't have much information from studies specifically looking at pregnancy with these conditions. The main goal is to gather more insight into these pregnancy complications. By understanding them better, doctors can develop improved ways to prevent problems and make pregnancy safer, ultimately reducing the risk of death for mothers and babies. Doctors and patient groups believe new scientific information is needed to create better guidelines for care.

At a glance

Status
Recruiting
Sponsor
Hospices Civils de Lyon
Enrolment target
400
Start
06 Feb 2020
Estimated completion
01 Nov 2028

What is this study about?

This study is called the COGRare5 Study, and it's looking into how pregnancy is affected when a woman has certain rare conditions that involve her blood vessels. These conditions include things like Osler Rendu disease (which can cause bleeding), Marfan syndrome (which affects various parts of the body, including blood vessels), primary lymphedema (swelling due to issues with the lymphatic system), and different types of arteriovenous malformations (AVMs), which are unusual connections between arteries and veins in places like the brain or spinal cord.

While these conditions can be challenging on their own, when a woman who has one becomes pregnant, there's a risk of complications that could be very serious for both her and her baby. Right now, there isn't a lot of research specifically following pregnancies in women with these particular conditions. This means doctors don't have all the information they need to best advise and care for these mothers-to-be.

The main purpose of this study is to gather more information about what happens during pregnancy for women with these rare blood vessel conditions. By understanding the challenges and complications better, doctors hope to find new ways to prevent problems, improve care, and ultimately make pregnancy safer for both mother and child. Experts and patient groups agree that this kind of research is really important to develop up-to-date, science-backed guidance for doctors and patients.

Key takeaways

  • This study aims to understand pregnancy with rare blood vessel conditions better.
  • It covers conditions like Osler Rendu disease, Marfan syndrome, and certain AVMs.
  • Participation involves completing a questionnaire about your pregnancy experience.
  • There are no new treatments or extra medical tests involved.
  • The goal is to improve care and reduce risks for mothers and babies in the future.
  • You must be pregnant or have given birth recently and have one of the listed conditions.

Who may be eligible?

To join this study, you need to be a woman who is between 18 and 45 years old.

You should either be pregnant right now, or have given birth less than one month ago (within 30 days of the study start). A doctor must have confirmed that you have one of these rare blood vessel conditions, either before you got pregnant, during your pregnancy, or within one month after you gave birth. This diagnosis might have been made through a physical check, scans, or blood tests.

Finally, you need to understand what the study involves and agree to take part. You cannot join if you don't meet these requirements or if you are legally unable to make decisions for yourself.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you a woman between 18 and 45 years old?
  2. Are you currently pregnant or have you given birth in the last month (30 days or less)?
  3. Have you been diagnosed with a rare blood vessel condition (like Osler Rendu disease, Marfan Syndrome, primary lymphedema, or specific AVMs)?
  4. Was this diagnosis made before, during, or within one month after your pregnancy?
  5. Are you able to understand and agree to take part in the study?
Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, your involvement would be quite straightforward. You would be asked to complete a questionnaire. This questionnaire will ask you questions about your pregnancy and your health condition. There are no visits required beyond your normal medical appointments, no new medications to take, and no extra tests or procedures. The study is gathering information through this questionnaire to learn more about these rare conditions during pregnancy.

Potential risks and benefits

The potential benefits of taking part in this study are indirect; you would be contributing valuable information that could help future mothers with similar conditions. By sharing your experience, you'll help doctors better understand these rare conditions and develop improved care. There are no direct medical benefits to you. Given that your involvement is limited to completing a questionnaire, the direct risks are very low, mainly the time taken to answer the questions. Your information will be kept confidential. Remember, deciding whether or not to take part is completely up to you, and you can withdraw from the study at any time without it affecting your medical care.

Locations (36)

  • Service de Médecine Interne et Maladies Vasculaires + Service Neuropédiatrie et neurochirurgie de l'enfant - CHU Angers
    Verified postcode
    Angers, France· Recruiting
  • Service de Médecine interne et immunologie clinique + Service de Médecine Vasculaire - Hôpital Saint André, CHU de Bordeaux
    Verified postcode
    Bordeaux, France· Withdrawn
  • Service Pneumologie et Oncologie Thoracique - AP-HP Hôpital Ambroise Paré
    Verified postcode
    Boulogne-Billancourt, France· Recruiting
  • Centre de Référence pour la maladie de Rendu-Osler - Service Génétique Clinique - Hôpital Femme-Mère-Enfant - Hospices Civils de Lyon
    Verified postcode
    Bron, France· Recruiting
  • Service d'imagerie médicale - Neuroradiologie interventionnelle - Hôpital Neurologique P. Wertheimer - HCL
    Verified postcode
    Bron, France· Withdrawn
  • Service d'Imagerie Pédiatrique et Fœtale et Consultation Pluridisciplinaire des Angiomes - Hôpital Femme-Mère-Enfant - HCL
    Verified postcode
    Bron, France· Recruiting
  • Service de Génétique, Hôpital Femme-Mère-Enfant
    Verified postcode
    Bron, France· Recruiting
  • Service de Médecine Vasculaire - Hôpital de la Côte de Nacre
    Verified postcode
    Caen, France· Recruiting
  • Service Médecine Interne Estaing CHU de Clermont-Ferrand - Hôpital d'Estaing
    Verified postcode
    Clermont-Ferrand, France· Recruiting
  • CHU Dijon Bourgogne - Hôpital François Mitterrand
    Verified postcode
    Dijon, France· Recruiting
  • Service de Médecine vasculaire et HTA - Hôpital Albert Calmette, CHRU de Lille
    Verified postcode
    Lille, France· Recruiting
  • Service Médecine interne - CHRU de Lille - Hôpital Claude Huriez
    Verified postcode
    Lille, France· Recruiting

Common questions

What kind of rare conditions are included in this study?

This study focuses on rare conditions affecting blood vessels, such as Osler Rendu disease, Marfan syndrome, primary lymphedema, and certain unusual connections in blood vessels (AVMs).

Will I have to take any new medicines or have extra tests?

No, if you join this study, you won't need to take any new medicines or have any extra tests beyond what your doctor already recommends for your care.

How long will my involvement in the study last?

Your involvement in this study would mainly be completing a questionnaire. It's not a long-term commitment requiring ongoing participation.

Who is running this study?

This is a national study focused on improving understanding and care for rare maternal vascular genetic disorders during pregnancy. It involves experts and patient associations.

Will my personal information be kept private?

Yes, any information you provide for the study will be kept confidential.

How to find out more

Sophie DUPUIS-GIROD, MD

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Pregnancy in Women With Rare Multisystemic Vascular Diseases…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.